Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Orgenesis Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q1 2024
- Shares held
- 2.19M
- −24.3K (−1.1%) vs. Q1 2024
- Total value
- $1.31M
- −$506.0K (−27.8%) vs. Q1 2024
- New holders
- 4
- 4 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $20.8K |
| Q1 2026 | 1 | $30.4K |
| Q4 2025 | 1 | $7.59K |
| Q3 2025 | 1 | $50.6K |
| Q2 2025 | 1 | $74.7K |
| Q1 2025 | 1 | $124.0K |
| Q4 2024 | 1 | $95.7K |
| Q3 2024 | 12 | $958.5K |
| Q2 2024 | 20 | $1.31M |
| Q1 2024 | 18 | $1.82M |
| Q4 2023 | 21 | $1.10M |
| Q3 2023 | 22 | $1.37M |
| Q2 2023 | 23 | $3.93M |
| Q1 2023 | 21 | $3.15M |
| Q4 2022 | 21 | $4.33M |
| Q3 2022 | 23 | $4.15M |
| Q2 2022 | 22 | $7.07M |
| Q1 2022 | 23 | $10.2M |
| Q4 2021 | 27 | $8.78M |
| Q3 2021 | 28 | $15.5M |
| Q2 2021 | 34 | $17.8M |
| Q1 2021 | 40 | $30.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Orgenesis Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 910,250 | $546.1K | 0.00% | −14,863−1.6% | Reduced |
| Knoll Capital Management, LLC | 634,738 | $380.8K | 0.26% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 283,077 | $169.9K | 0.00% | −4,878−1.7% | Reduced |
| BlackRock Inc. | 79,889 | $47.9K | 0.00% | −45,336−36.2% | Reduced |
| State Street Corp | 78,878 | $47.3K | 0.00% | +11,219+16.6% | Added |
| Northern Trust Corp | 40,512 | $24.3K | 0.00% | −161−0.4% | Reduced |
| Bank Hapoalim BM | 32,052 | $19.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 29,499 | $17.7K | 0.00% | −5,100−14.7% | Reduced |
| Redwood Financial Network Corp | 25,000 | $15.0K | 0.01% | 00.0% | Unchanged |
| Chapin Davis, Inc. | 20,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 18,330 | $11.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 16,280 | $9.77K | 0.00% | +16,280 | New |
| Virtu Financial LLC | 12,112 | $7.00K | 0.00% | +12,112 | New |
| UBS Group AG | 6,273 | $3.76K | 0.00% | +6,273 | New |
| Tower Research Capital LLC (TRC) | 631 | $379 | 0.00% | +631 | New |
| Bank of America Corp | 464 | $278 | 0.00% | +264+132.0% | Added |
| JPMorgan Chase & Co | 159 | $95 | 0.00% | +4+2.6% | Added |
| BNP Paribas Arbitrage, SA | 75 | $45 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 465 | $0 | 0.00% | +361+347.1% | Added |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −852−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −242−100.0% | Sold out |